12:00 AM
 | 
Jul 01, 2013
 |  BC Week In Review  |  Clinical News  |  Preclinical Results

Rhizen, TG Therapeutics preclinical data

In vitro, TGR-1202 inhibited B cell proliferation and induced CD63 expression. Additionally, TGR-1202 inhibited cell growth and induced apoptosis in MM cell lines. Data were presented...

Read the full 118 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >